Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

University of Verona, Verona, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Verona
Treatments:ChemotherapyHospital:University of Verona
Drugs:Journal:Link
Date:Jul 2006

Description:

Patients: This Phase II trial involved a total of 44 patients with advanced non-small-cell lung cancer. There were 36 men and 8 women. The median age was 70.

Treatment: The treatment consisted of chemotherapy – Gemcitabine and Vindesine.

Toxicity: There was one grade 4 toxicity – febrile neutropenia. Grade 3 toxicities included hematological, dermatological, paresthesias, fatigue and alopecia.

Results: The median overall survival was 12 months

Correspondance: Antonio Santo, MD





Back